Photo of: Bob Seeman

Mr. Bob Seeman

View Title...

California State Bar
Bob's profile was created using:
Sort By:

1-10 of 19 online sources for Bob Seeman

  • View Online Source
    www.techvision.com/press/detail.php?id=2 - [Cached Version]
    Published on: 1/7/2004    Last Visited: 3/25/2007  

    "biopartnering.com is the best pharmaceutical and biotechnology partnering online tool that I have used," stated Mr. Bob Seeman, CEO of Clera, Inc.

  • View Online Source
    web1.marsdd.com/MaRS-Centre/Our-Tenants/Clera-Inc-.html - [Cached Version]
    Published on: 10/11/2008    Last Visited: 9/6/2008  

    Bob Seeman, Founder, Chairman and CEOT 416-923-8540F 416-352-5071

  • View Online Source
    www.eurobiotechforum.com/content/Main.aspx - [Cached Version]
    Published on: 12/16/2004    Last Visited: 10/24/2006  

    - Bob Seeman CEO, Clera Inc.

  • View Online Source
    www.biofinance.ca/CleraInc - [Cached Version]
    Published on: 4/24/2007    Last Visited: 11/2/2007  

    , Bob Seeman, BASc, JD, MBA, Founder, Chairman & Chief Executive Officer
    ...
    Bob Seeman, Founder, Chairman & CEO260 Heath Street W. Suite 605 Toronto M5P 3L6Telephone: +1 416 923 8540Facsimile: + 1 416 352 5071

  • View Online Source
    www.biofinance.ca/CleraInc08 - [Cached Version]
    Published on: 10/11/2008    Last Visited: 7/27/2008  

    Bob Seeman, BASc LLB, MBA - co-founder, Chairman & CEO

  • View Online Source
    Breaking News: Clera Announces Senior Management... - [Cached Version]
    Published on: 5/23/2006    Last Visited: 5/23/2006  

    With the company's recent achievements, it is the right time to begin solidifying Clera's management team with experienced industry executives," said Mr. Bob Seeman, Founder, Chairman and CEO of Clera."I am very pleased that these two highly accomplished individuals are joining our company.They are tremendous people who have the background to help lead Clera's growth and the advancement of our CNS pipeline."

    Mr. Seeman also noted that Clera expects to add additional drug development expertise to its team in the near future.He will be presenting the Clera story at the 8th Annual C21 BioVentures Life Sciences Private Equity Conference on Wednesday, May 24, 2006 at 2 p.m.
    ...
    Bob Seeman, 416-923-8540 pr@clera.com

    Email Article Print Article

  • View Online Source
    Clera Announces Senior Management Appointments:... - [Cached Version]
    Published on: 5/23/2006    Last Visited: 5/23/2006  

    With the company's recent achievements, it is the right time to begin solidifying Clera's management team with experienced industry executives," said Mr. Bob Seeman, Founder, Chairman and CEO of Clera."I am very pleased that these two highly accomplished individuals are joining our company.They are tremendous people who have the background to help lead Clera's growth and the advancement of our CNS pipeline."

    Mr. Seeman also noted that Clera expects to add additional drug development expertise to its team in the near future.He will be presenting the Clera story at the 8th Annual C21 BioVentures Life Sciences Private Equity Conference on Wednesday, May 24, 2006 at 2 p.m.
    ...
    Bob Seeman, 416-923-8540 pr@clera.com

  • View Online Source
    Clera Inc - Team - [Cached Version]
    Published on: 9/8/2006    Last Visited: 9/8/2006  

    Bob Seeman, Chief Executive Officer

    Bob has been CEO since Clera's founding in 2001.Previously, he was CEO of an electronic certification company and a partner in Origin Strategy, an intellectual property consulting firm.He has also been Head of Strategy for Microsoft Network UK and an advisor to BioCAD.

    Bob previously practiced law with Bull, Housser & Tupper, a full-service Canadian law firm.He holds a B.A.Sc. with Honours from the University of Toronto, an M.B.A. from France's Theseus International Management Institute, and an LL.B. from the University of British Columbia.He is a non- practicing member of the California State Bar.He has published on a wide variety of technical issues including articles in the Can.Med.Assoc. Journal and the Int.Journal of Psychosocial Rehabilitation.

  • View Online Source
    Clera Inc. - [Cached Version]
    Published on: 12/26/2006    Last Visited: 12/26/2006  

    With the company's recent achievements, it is the right time to begin solidifying Clera's management team with experienced industry executives," said Mr. Bob Seeman, Founder, Chairman and CEO of Clera."I am very pleased that these two highly accomplished individuals are joining our company.They are tremendous people who have the background to help lead Clera's growth and the advancement of our CNS pipeline."

    Mr. Seeman also noted that Clera expects to add additional drug development expertise to its team in the near future.He will be presenting the Clera story at the 8th Annual C21 BioVentures Life Sciences Private Equity Conference on Wednesday, May 24, 2006 at 2 p.m..

  • View Online Source
    Clera Inc. - [Cached Version]
    Published on: 1/28/2004    Last Visited: 1/28/2004  

    Bob Seeman, M.B.A., LL.B, B.A.Sc., Co-Founder & Chief Executive Officer Bob has been CEO since Clera's founding in 2001.Previously, he was CEO of an electronic certification company and a partner in Origin Strategy, an intellectual property consulting firm.He has also been Head of Strategy for Microsoft Network UK and an advisor to BioCAD.Bob previously practiced law with Bull, Housser & Tupper, a full-service Canadian law firm.He holds a B.A.Sc. with Honours from the University of Toronto, an M.B.A. from France's Theseus International Management Institute, and an LL.B. from the University of British Columbia.He is a non-practicing member of the California State Bar.He has published on a wide variety of technical issues including articles in the Can.Med.Assoc. Journal and the Int.Journal of Psychosocial Rehabilitation.
    ...
    Mr. Bob Seeman - CEO p: 416-923-8540

Page:  1 2 Next

Wrong Person?

Related searches
More...
For Recruiters For Sales Pros

Copyright © 2008 Zoom Information Inc. All rights reserved.

BPS_S5.0.5_newui_RC002_P001.1 OM11